[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
History of Neurology
July 2004

Alfred Hauptmann, Siegfried Thannhauser, and an Endangered Muscular Disorder

Author Affiliations

From the Department of Neurology, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany.

 

CHRISTOPHER G.GOETZMD

Arch Neurol. 2004;61(7):1139-1141. doi:10.1001/archneur.61.7.1139

Alfred Hauptmann (Figure 1), a German neurologist who initially introduced phenobarbital in epilepsy therapy, and Siegfried Thannhauser (Figure 2), an outstanding German metabolism specialist, left Germany during the Nazi regime because of their Jewish origin. Both scientists emigrated to the United States and, in 1941, described a new myopathic entity,1 later called Hauptmann-Thannhauser muscular dystrophy. Recently, this eponym has largely disappeared from the literature and has been replaced with the term autosomal dominant form of Emery-Dreifuss muscular dystrophy. However, molecular biology as well as more in-depth clinical studies argue that Hauptmann-Thannhauser muscular dystrophy is a distinct entity. On the basis of their discovery and their important contributions in other neurological spheres, we suggest a reinstatement of the term Hauptmann-Thannhauser muscular dystrophy in modern neurological nosology.

First Page Preview View Large
First page PDF preview
First page PDF preview
×